Literature DB >> 23839589

[Genital reassignment surgery in male-to-female transsexuals: do we have guidelines or standards?].

M H Sohn1, M Hatzinger, K Wirsam.   

Abstract

BACKGROUND: In 2011 the WPATH (World Professional Association for Transgender Health) published the 7th version of their "Standards of Care" for diagnosis and treatment of transsexual people. In face of further recent peer-reviewed reports of experienced centres on surgical sex reassignment it should be examined whether or not genital sex reassignment in male-to-female transsexuals actually can be based on evidence-based guidelines or standards.
RESULTS: The indication for surgery is widely standardised and evidence-based. Most critical steps of the operation are also founded on grade B recommendations. Most experienced authors rely on penoscrotal pedicled flaps for neovaginal lining. The topic of ideal reconstruction of the vulva, especially the clitoro-labial complex is still a field of debate. Due to the high frequency of further corrective surgeries which exceeds 50% in most experienced centres, some authors prefer a primary 2-step procedure for genital reassignment.
CONCLUSIONS: The indication and principal operative steps in surgical genital reassignment in male-to-female patients rely on evidence-based recommendations. By respecting these recommendations subjective success rates of over 80% can be expected. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23839589     DOI: 10.1055/s-0033-1343427

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  2 in total

1.  Satisfaction with male-to-female gender reassignment surgery.

Authors:  Jochen Hess; Roberto Rossi Neto; Leo Panic; Herbert Rübben; Wolfgang Senf
Journal:  Dtsch Arztebl Int       Date:  2014-11-21       Impact factor: 5.594

2.  Sexuality after Male-to-Female Gender Affirmation Surgery.

Authors:  J Hess; A Henkel; J Bohr; C Rehme; A Panic; L Panic; R Rossi Neto; B Hadaschik; Y Hess
Journal:  Biomed Res Int       Date:  2018-05-27       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.